Establishment of NAFLD Cohort and Development of Fibrosis Markers
ConditionFibrosis of Liver
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSeoul National University Boramae Hospital
About this trial
This study is designed for establishment of non-alcoholic fatty liver disease patients cohort to development of markers to predict histologic progression of liver fibrosis.
Eligibility criteria
Qualifiers
Patients with histologically confirmed fatty liver disease
Patients with radiologically confirmed fatty liver disease
Disqualifiers
History of significant alcohol consumption
Viral hepatitis
Autoimmune hepatitis
Metabolic diseases (e.g. hemochromatosis, M. Wilson, alpha 1-antitrypsin deficiency)
Trial design
Treatments tested in this trial
- Liver biopsy
- ARFI
- SWE
- Transient elastography
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov